BibTex RIS Cite

The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections

Year 2007, Volume: 2 Issue: 3, 0 - , 07.09.2015

Abstract

Eighty four men patients with the complaints of urethritis were included. In this research, Mycoplasma IST (BioMérieux sa, France) kit was used for investigation of Ureaplasma urealyticum in the urine samples obtained from patients. By using mycoplasma IST information about the presence or absence of Ureaplasma urealyticum provided. Besides Mycoplasma hominis and their antimicrobial susceptibilities to antimicrobial agents (pristinamycine, doxycycline, josamycin, erythromycine, tetracycline, ofloxacin) were determined. U. urealyticum strains were isolated from 60 (71.43%) patients and M. hominis strain was not isolated from any patient. U. urealyticum isolates were found to be sensitive 100% to tetracycline, 100%
to ofloxacin, 95% to doxycycline, 95% to josamycin, 90% to pristinamycin, 88.3% to erythromycin.

The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections

Year 2007, Volume: 2 Issue: 3, 0 - , 07.09.2015

Abstract

Üretritis şikayeti ile başvuran 84 erkek hasta, çalışmaya dahil edildi. Bu çalışmada, hastalardan alınan idrar örneklerinde Ureaplasma urealyticum araştırılması için Mycoplasma IST (BioMérieux sa, France) kiti kullanıldı. Mycoplasma IST kiti ile Ureaplasma urealyticum ve Mycoplasma hominis bulunup bulunmadığının yanı sıra saptanan organizmaların antimikrobiyal ajanlara (doksisiklin, josamisin, ofloksasin, eritromisin, tetrasiklin, pristinamisin) duyarlılıkları belirlendi. Üretritis’li hastaların 60’ından (%71.43) U.urealyticum izole edilirken, hiçbir hastada M. hominis izole edilmedi. U.urealyticum izolatlarının %100’ü tetrasikline, %100’ü ofloksasine, %95’i doksisikline, %95’i josamisine, %90’ı pristinamisin ve %88.3’ü eritromisine duyarlı bulundu.

There are 0 citations in total.

Details

Primary Language Turkish
Journal Section Araştırma Makaleleri
Authors

İrfan Sevinç This is me

Ekrem Kireçci This is me

Publication Date September 7, 2015
Published in Issue Year 2007 Volume: 2 Issue: 3

Cite

APA Sevinç, İ., & Kireçci, E. (2015). The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 2(3).
AMA Sevinç İ, Kireçci E. The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. September 2015;2(3).
Chicago Sevinç, İrfan, and Ekrem Kireçci. “The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections”. Atatürk Üniversitesi Veteriner Bilimleri Dergisi 2, no. 3 (September 2015).
EndNote Sevinç İ, Kireçci E (September 1, 2015) The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections. Atatürk Üniversitesi Veteriner Bilimleri Dergisi 2 3
IEEE İ. Sevinç and E. Kireçci, “The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections”, Atatürk Üniversitesi Veteriner Bilimleri Dergisi, vol. 2, no. 3, 2015.
ISNAD Sevinç, İrfan - Kireçci, Ekrem. “The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections”. Atatürk Üniversitesi Veteriner Bilimleri Dergisi 2/3 (September 2015).
JAMA Sevinç İ, Kireçci E. The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2015;2.
MLA Sevinç, İrfan and Ekrem Kireçci. “The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections”. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, vol. 2, no. 3, 2015.
Vancouver Sevinç İ, Kireçci E. The Prevalence and Antimicrobial Susceptibilities of Ureaplasma Urealyticum Isolates in Urogenital Infections. Atatürk Üniversitesi Veteriner Bilimleri Dergisi. 2015;2(3).